Zhejiang Jolly Pharmaceutical News

Zhejiang Jolly Pharmaceutical: 2024 Interim Performance Forecast

Jul 10 06:36 ET

Zhejiang Jolly Pharmaceutical: Investor relations activity record from June 26th to June 28th, 2024.

Jun 28 10:01 ET

Zhejiang Jolly Pharmaceutical: Investor Relations Activity Record Form | June 20, 2024

Jun 23 05:18 ET

Zhejiang Jolly Pharmaceutical: Investor Relations Activity Schedule for May 30, 2024

May 31 08:12 ET

Zhejiang Jolly Pharmaceutical: May 22, 2024 to May 23, 2024 Investor Relations Activity Record

May 24 06:12 ET

Zhejiang Jolly Pharmaceutical: Announcement on the progress of providing guarantees for holding subsidiaries to apply for credit lines from banks

May 24 05:24 ET

Zhejiang Jolly Pharmaceutical: Record of Investor Relations Activities from May 15, 2024 to May 17, 2024

May 17 09:06 ET

Zhejiang Jolly Pharmaceutical: 2023 Annual Equity Distribution Implementation Notice

May 15 06:34 ET

Zhejiang Jolly Pharmaceutical: May 10, 2024 Investor Relations Activity Schedule

May 14 07:00 ET

Zhejiang Jolly Pharmaceutical: Notice on Reixiang tablets receiving approval notice for drug clinical trials

May 14 05:26 ET

Zhejiang Jolly Pharmaceutical: Announcement of Resolutions of the First Meeting of the Eighth Board of Supervisors

May 10 07:46 ET

Zhejiang Jolly Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

May 10 07:45 ET

Zhejiang Jolly Pharmaceutical: Announcement on the completion of the election of the Board of Directors and the Board of Supervisors and the appointment of senior managers, heads of audit departments, and representatives of securities affairs

May 10 07:44 ET

Zhejiang Jolly Pharmaceutical: Legal Opinion of Shanghai Oriental Huayin Law Firm on the 2023 Annual General Meeting of Shareholders of Zhejiang Zuoli Pharmaceutical Co., Ltd.

May 10 07:44 ET

Zhejiang Jolly Pharmaceutical: Announcement of the resolution of the first meeting of the 8th Board of Directors

May 10 07:44 ET

Zhejiang Jolly Pharmaceutical: Notice on the company's senior management receiving the Zhejiang Securities Regulatory Bureau's regulatory dialogue measures decision

Apr 30 05:02 ET

Zhejiang Jolly Pharmaceutical: Announcement on short-term transactions and apologies for senior managers' relatives

Apr 30 05:02 ET

Zhejiang Jolly Pharmaceutical: April 25, 2024 2023 Online Results Briefing Investor Relations Activity Record Form

Apr 25 06:36 ET

Zuoli Pharmaceuticals: Investor Relations Activity Record Form for April 21, 2024

Apr 23 11:07 ET

Zuoli Pharmaceutical: Announcement on holding the 2023 Online Results Briefing

Apr 19 06:12 ET